DK0487575T3 - Farmaceutiske formuleringer - Google Patents

Farmaceutiske formuleringer

Info

Publication number
DK0487575T3
DK0487575T3 DK90912234.3T DK90912234T DK0487575T3 DK 0487575 T3 DK0487575 T3 DK 0487575T3 DK 90912234 T DK90912234 T DK 90912234T DK 0487575 T3 DK0487575 T3 DK 0487575T3
Authority
DK
Denmark
Prior art keywords
fat
soluble
gelatin capsules
hard gelatin
optionally
Prior art date
Application number
DK90912234.3T
Other languages
Danish (da)
English (en)
Inventor
Michael John Story
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898918809A external-priority patent/GB8918809D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Application granted granted Critical
Publication of DK0487575T3 publication Critical patent/DK0487575T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK90912234.3T 1989-08-17 1990-08-17 Farmaceutiske formuleringer DK0487575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898918809A GB8918809D0 (en) 1989-08-17 1989-08-17 Pharmaceutical formulations
US08/430,500 US5738871A (en) 1989-08-17 1995-04-28 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK0487575T3 true DK0487575T3 (da) 1994-11-28

Family

ID=26295779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90912234.3T DK0487575T3 (da) 1989-08-17 1990-08-17 Farmaceutiske formuleringer

Country Status (13)

Country Link
US (1) US5738871A (fr)
EP (1) EP0487575B1 (fr)
JP (1) JPH04507418A (fr)
AT (1) ATE113471T1 (fr)
AU (1) AU633959B2 (fr)
CA (1) CA2063791C (fr)
DE (1) DE69013923T2 (fr)
DK (1) DK0487575T3 (fr)
ES (1) ES2062543T3 (fr)
FI (1) FI920646A0 (fr)
HK (1) HK85196A (fr)
NO (1) NO302333B1 (fr)
WO (1) WO1991002520A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DE69426408T2 (de) * 1993-09-28 2001-07-12 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
KR100293297B1 (ko) * 1995-11-24 2001-08-07 씨.지. 온닝크 어유기재조성물
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AUPP022297A0 (en) 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
TW367247B (en) * 1998-02-03 1999-08-21 Otsuka Pharma Co Ltd Storage container for Vitamin D solution and transfusion container
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
GB0101198D0 (en) 2001-01-17 2001-02-28 Scherer Technologies Inc R P Ingestible compositions containing an odoriferous oil
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
NZ536267A (en) * 2002-04-10 2007-06-29 Fred H Miller Multi-phase, multi-compartment and multi-ingredient capsular system
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
CA2560298A1 (fr) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited Preparation en teneur elevee
AU2005329255B2 (en) 2004-04-15 2010-09-30 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
CN101005768B (zh) * 2004-08-31 2012-07-11 阿克佐诺贝尔股份有限公司 颜料的增溶方法和颜料组合物及其用途
MX2009000118A (es) 2006-06-27 2009-01-26 Akzo Nobel Nv Formulaciones que comprenden una vitamina y el uso de las mismas para elaborar alimento fortificado para animales y formulaciones para el cuidado personal.
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物
EP2296682B8 (fr) 2008-04-29 2018-07-04 Nikken Sohonsha Corporation Procédés de traitement de troubles ophtalmiques
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
CN104146955A (zh) 2009-03-09 2014-11-19 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
EP2490678B1 (fr) * 2009-10-23 2021-08-04 Basf As Capsules ou comprimés enrobés d'un mélange oléagineux d'acides gras
US10610528B2 (en) * 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US8722131B2 (en) 2010-09-07 2014-05-13 Dsm Nutritional Products Ag Comestible emulsions
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
RU2708238C2 (ru) 2014-06-17 2019-12-05 Мерк Шарп и Доум Б.В. Стабильные составы тестостерона ундеканоата
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
KR102678365B1 (ko) * 2018-03-20 2024-06-26 재단법인 경기도경제과학진흥원 콜레칼시페롤의 가용화 조성물 및 그 제조방법
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JPH01233218A (ja) * 1988-03-15 1989-09-19 Daikyo Yakuhin Kogyo Kk ビタミン組成物
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations

Also Published As

Publication number Publication date
NO302333B1 (no) 1998-02-23
JPH04507418A (ja) 1992-12-24
DE69013923T2 (de) 1995-03-16
CA2063791C (fr) 2000-12-19
DE69013923D1 (de) 1994-12-08
ATE113471T1 (de) 1994-11-15
AU633959B2 (en) 1993-02-11
EP0487575A1 (fr) 1992-06-03
NO920604D0 (no) 1992-02-14
AU6161990A (en) 1991-04-03
EP0487575B1 (fr) 1994-11-02
FI920646A0 (fi) 1992-02-14
US5738871A (en) 1998-04-14
WO1991002520A1 (fr) 1991-03-07
HK85196A (en) 1996-05-24
ES2062543T3 (es) 1994-12-16
CA2063791A1 (fr) 1991-02-18
NO920604L (no) 1992-02-14

Similar Documents

Publication Publication Date Title
ES2062543T3 (es) Formulaciones farmaceuticas.
CO4761073A1 (es) Preparados que contienen ciclosporina
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
EP0165352A3 (fr) Solutions micellaires liquides d'agents nutritifs essentiels oléosolubles
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
DK1341527T3 (da) Farmaceutisk præparat omfattende et aktivstof dispergeret på en matrix
DK0750495T3 (da) Anvendelse af et lipofilt overfladeaktivt middel i et farmaceutisk præparat
CO4970836A1 (es) Formulaciones inyectables de larga accion que contienen aceite de castor hidrogenado
HRP20010615B1 (en) Pharmaceutical compositions containing proton pump inhibitors
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
GR3001312T3 (en) Pharmaceutical composition containing 2-(2-fluoro-4-biphenylyl)propionic acid or a salt thereof
YU17899A (sh) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
DK206387A (da) Anvendelse af glucofurol til flydende-goeren af laegemiddelpraeparater til fyldning i bloede gelatinkapsler
ES2051827T3 (es) Una composicion farmaceutica que contiene aceite de ricino polietoxilado.
AR002759A1 (es) Composiciones farmaceuticas en dosis unitarias, que incluyen inhibidores de proteinasa.
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
JPS5764609A (en) Cyclophosphamide composition for rectal administration
GB1133845A (en) Pharmaceutical compositions comprising dextran and cellulose ethers
ATE155041T1 (de) Rectale pharmazeutische zubereitung fuer die behandlung von prostataanschwellung